Techniques of pregnancy termination. Part II.
D000019:Abortifacient Agents / Q000008:administration & dosage; D000028:Abortion, Induced / Q000009:adverse effects / Q000379:methods*; D000029:Abortion, Legal; D001778:Blood Coagulation Disorders / Q000209:etiology; D005260:Female; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D006955:Hypernatremia / Q000209:etiology; D006982:Hypertonic Solutions; D007239:Infections / Q000209:etiology; D009994:Osmolar Concentration; D010121:Oxytocin / Q000008:administration & dosage; D010743:Phospholipids / Q000008:administration & dosage; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011277:Pregnanediones / Q000502:physiology; D011374:Progesterone / Q000502:physiology; D011453:Prostaglandins / Q000008:administration & dosage; D012965:Sodium Chloride; D013997:Time Factors; D014620:Vacuum Extraction, Obstetrical; D014869:Water Intoxication / Q000209:etiology
D000019:Abortifacient Agents; D006982:Hypertonic Solutions; D010743:Phospholipids; D011277:Pregnanediones; D011453:Prostaglandins; D012965:Sodium Chloride; D011374:Progesterone; D010121:Oxytocin